U.S. markets close in 1 hour 3 minutes
  • S&P 500

    -7.68 (-0.20%)
  • Dow 30

    -43.26 (-0.14%)
  • Nasdaq

    -61.69 (-0.53%)
  • Russell 2000

    +11.46 (+0.65%)
  • Crude Oil

    +1.86 (+1.73%)
  • Gold

    -5.00 (-0.27%)
  • Silver

    +0.01 (+0.07%)

    +0.0029 (+0.28%)
  • 10-Yr Bond

    +0.0770 (+2.46%)

    +0.0008 (+0.06%)

    +0.2630 (+0.19%)

    -382.71 (-1.80%)
  • CMC Crypto 200

    -7.95 (-1.72%)
  • FTSE 100

    +49.51 (+0.69%)
  • Nikkei 225

    +379.30 (+1.43%)

Global Contraceptive Drugs Market Size Worth USD 16.5 Billion, by 2028 at 5.4% CAGR – Contraceptive Drugs Industry Report by Vantage Market Research

·11 min read
Vantage Market Research, The North Star for the Working World
Vantage Market Research, The North Star for the Working World

WASHINGTON, June 23, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Contraceptive Drugs Market finds that the rise in concerns about family planning and an increasing need to avoid unintended pregnancy are some of the major factors propelling the growth of the Global Contraceptive Drugs Market. Contraception pills are majorly used to avoid unwanted pregnancy, control the birth rate, and minimize the risk of sexually transmitted diseases (STDs). Therefore, it expands rapidly in the coming years. In addition, upward use of contraception among young women and growing higher educational achievement bolster the Contraceptive Drugs Market growth.

The Global Market revenue stood at a value USD 12.1 Billion in the year 2021.

The Global Contraceptive Drugs Market size is forecasted to reach USD 16.5 Billion by the year 2028 and is expected to grow to exhibit a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period; states Vantage Market Research, in a report, titled “Contraceptive Drugs Market Size, Share & Trends Analysis Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), by Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), by End User (Homecare, Hospitals, Clinics), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/contraceptive-drugs-market-1674/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

  • The newly updated, 140+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.

  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.

  • We offer these reports in PDF format so you can read them on your computer and print them out.

  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.

  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.

  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

Market Dynamics:


Rise in Awareness of Contraceptive Drugs Market Drives the Market

The upsweep in the use of contraception has decreased the risk of sexually radiated infections and enhanced health-related outcomes comprising maternal & infant mortality. Additionally, an upsweep in the number of gynaecologists preferring these contraception devices for the intention of birth control is going to prompt the industry's growth in forthcoming years. An increase in awareness of modern contraceptives, increasing use of safe & effective oral pills, and health complications correlated to teenage pregnancies stimulate the market expansion.

The contraceptive devices will provide the maximum growth of the Contraceptive Drugs Market. Contraceptive devices are estimated to capture more than half of the Global Contraceptive Drugs Market during the forecast period. With this ever-increasing risk, there is an increase in awareness about modern contraceptives. Governments across the world have steadily invested in family planning and sex education programs to escalate awareness about the dangers of STDs, which has also augmented the growth of the Contraceptive Drugs Market.


Fear of Side Effects Due to Lack of Awareness

The oral contraceptive pill is hormonal contraception therapy. Side effects of these pills are prevalent and may differ from one person to another. Long-term usage of birth control pills is linked to adverse effects, which include bleeding, headaches, nausea, and weight gain. Several research articles have been released to draw attention to the long-term negative effects of birth control pills. The lack of understanding while using these long-term contraceptive pills leads to apprehension about accepting them. In addition, in underdeveloped countries, the social stigma connected with the use of contraception methods, as well as the expensive cost of these methods and pills are blamed for the low uptake and acceptability of these methods.

Key Insights & Findings from the Report:

  • According to our primary respondents’ research, the Contraceptive Drugs market is predicted to grow at a CAGR of roughly 5.4% during the forecast period.

  • The Contraceptive Drugs market was estimated to be worth roughly USD 12.1 Billion in 2021 and is expected to reach USD 16.5 Billion by 2028; based on primary research.

  • On the basis of region, Asia Pacific is projected to dominate the worldwide Contraceptive Drugs market.

Purchase This Premium Report (Price 4500 USD for a single-user license) at @ https://www.vantagemarketresearch.com/buy-now/contraceptive-drugs-market-1674/0

Benefits of Purchasing Contraceptive Drugs Market Reports:       

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.

  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.

  • Assured Quality: Focuses on accuracy and quality of reports.

  • Incomparable Skills: Analysts provide in-depth insights into reports.

Segmentation of the Global Contraceptive Drugs Market:

  • Product

    • Oral Contraceptive Pills

    • Injectable Contraceptives

    • Topical Contraceptives

  • Age Group

    • 15–24 Years

    • 25–34 Years

    • 35–44 Years

    • Above 44 Years

  • End User

    • Homecare

    • Hospitals

    • Clinics

  • Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/contraceptive-drugs-market-1674

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the healthcare industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

  1. Impact Assessment of COVID-19 Pandemic

    1. North America

    2. Europe

    3. Asia Pacific

    4. Latin America

    5. Middle East & Africa

  2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021

  3. Key Strategies Undertaken by Companies to Tackle COVID-19

  4. Long Term Dynamics

  5. Short Term Dynamics

The Report on Contraceptive Drugs Market Highlights:

  • Assessment of the market

  • Premium Insights

  • Competitive Landscape

  • COVID Impact Analysis

  • Historic Data, Estimates, and Forecast

  • Company Profiles

  • Global and Regional Dynamics

Regional Analysis:

North America Dominated the Global Contraceptive Drugs Market

North America dominated the Contraceptive Drugs Market in 2021. The development in the Contraceptive Drugs Market is due to the existence of great population support, proactive advantages of governmental organizations for birth control, and awareness in underdeveloped countries. In addition, the accessibility of cost-effective Contraceptive Drugs Market in the region ensures possibilities for contraceptive drug producers. This is ascribed to increasing demand for contraceptive pills among the public as well as increased awareness of various contraceptive drug options. Birth control tablets are disposed of over the counter in numerous nations. As a result, clients are increasingly seeking birth control tablets in retail pharmacies.

Browse market data Tables and Figures spread through 144 Pages and in-depth TOC on "Contraceptive Drugs Market Size, Share & Trends Analysis Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), by Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), by End User (Homecare, Hospitals, Clinics), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

List of Prominent Players in the Contraceptive Drugs Market:

  • Agile Therapeutics

  • Allergan PLC

  • Bayer AG

  • GlaxoSmithKline PLC

  • Johnson & Johnson

  • Piramal Healthcare

  • Mylan N.V.

  • Pfizer Inc.

  • Novartis AG

  • Teva Pharmaceutical Industries Ltd.

Recent Developments:

February 2022: Organon acquired rights from Bayer AG to Marvelon and Mercilon, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, including Hong Kong and Macau, and has entered into an agreement to acquire the rights to these products in Vietnam.

April 2021: Mayne Pharma reported that the United States Food and Drug Administration (FDA) had approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens.

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?

  • Which are the top five players of the Contraceptive Drugs Market?

  • How will the Contraceptive Drugs Market change in the upcoming six years?

  • Which application and product will take a lion’s share of the Contraceptive Drugs Market?

  • What is the Contraceptive Drugs market drivers and restrictions?

  • What will be the CAGR and size of the Contraceptive Drugs Market throughout the forecast period?  

This market titled “Contraceptive Drugs Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:



Market Size Provided for Years


Base Year


Historic Years


Forecast Years


Segments Covered

• Product

   ° Oral Contraceptive Pills

   ° Injectable Contraceptives

   ° Topical Contraceptives

• Age Group

   ° 15–24 Years

   ° 25–34 Years

   ° 35–44 Years

   ° Above 44 Years

• End User

   ° Homecare

   ° Hospitals

   ° Clinics

• Region

   ° North America

   ° Europe

   ° Asia Pacific

   ° Latin America

   ° Middle East & Africa

Region & Counties Covered

• North America

   ° U.S.

   ° Canada

   ° Mexico

• Europe

   ° U.K

   ° France

   ° Germany

   ° Italy

   ° Spain

   ° Rest Of Europe

• Asia Pacific

   ° China

   ° Japan

   ° India

   ° South Korea

   ° South East Asia

   ° Rest Of Asia Pacific

• Latin America

   ° Brazil

   ° Argentina

   ° Rest Of Latin America

• Middle East & Africa

   ° GCC Countries

   ° South Africa

   ° Rest Of Middle East & Africa

Companies Covered

• Agile Therapeutics

• Allergan PLC

• Bayer AG

• GlaxoSmithKline PLC

• Johnson & Johnson

• Piramal Healthcare

• Mylan N.V.

• Pfizer Inc.

• Novartis AG

• Teva Pharmaceutical Industries Ltd.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/contraceptive-drugs-market-1674/request-sample

Browse More Related Report:

  • Cross-Border B2C E-Commerce Market to Reach Valuation of USD 3,042.2 Million by 2028 - The growth of online stores and e-commerce purchasing is Driving the Market Growth.

  • Cannabis Testing Market to Reach USD 2,669.45 Million by 2028.

  • B2B Payments Market to Reach 1,618.15 USD Billion by 2028.

  • Electric Truck Market to Reach Valuation of USD 1686.6 Million by 2028 - The Government's Focus on Zero-Emission Cars and Rules will Encourage the Use of Electric Trucks in the E-Commerce and Automotive Industries.

  • Ethanol Market to Reach Valuation of USD 117.5 Billion by 2028 – Changing Lifestyle and Disposable Income among the Global Population Drives the Market.

  • Green Hydrogen – The Future Fuel Set to Witness 50 - Fold Growth Increasing Investments & Government Policies to Boost Global Green Hydrogen Market.

  • Green Chemicals Market to Reach Valuation of 16684.27 USD Million by 2028; Increasing Adoption of Packaging Which is Bio-based is Driving the Market.

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs